Jérôme Rossert

16.9k total citations · 4 hit papers
107 papers, 11.4k citations indexed

About

Jérôme Rossert is a scholar working on Nephrology, Hematology and Immunology. According to data from OpenAlex, Jérôme Rossert has authored 107 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Nephrology, 28 papers in Hematology and 26 papers in Immunology. Recurrent topics in Jérôme Rossert's work include Erythropoietin and Anemia Treatment (23 papers), Chronic Kidney Disease and Diabetes (18 papers) and Dialysis and Renal Disease Management (14 papers). Jérôme Rossert is often cited by papers focused on Erythropoietin and Anemia Treatment (23 papers), Chronic Kidney Disease and Diabetes (18 papers) and Dialysis and Renal Disease Management (14 papers). Jérôme Rossert collaborates with scholars based in France, United States and Germany. Jérôme Rossert's co-authors include Kai‐Uwe Eckardt, Andrew S. Levey, Josef Coresh, Adeera Levin, Garabed Eknoyan, Norbert Lameire, Dick de Zeeuw, Yusuke Tsukamoto, Thomas H. Hostetter and Marc Froissart and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jérôme Rossert

106 papers receiving 11.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

2005 2.8k citations Andrew S. Levey, Kai‐Uwe Eckardt et al. Kidney International profile →
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2007 1.1k citations Andrew S. Levey, Josef Coresh et al. Kidney International profile →
Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

2008 811 citations Josef Coresh, Marc Froissart et al. American Journal of Kidney Diseases profile →
Predictive Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Estimating Renal Function

2005 603 citations Marc Froissart, Jérôme Rossert et al. Journal of the American Society of Nephrology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jérôme Rossert	4.6k	1.8k	1.5k	1.5k	1.4k	107	11.4k
Christian Combe	4.9k 1.1×	1.1k 0.6×	802 0.5×	1.0k 0.7×	880 0.6×	338	10.3k
Lee A. Hebert	4.8k 1.0×	1.0k 0.6×	1.7k 1.1×	1.8k 1.2×	1.9k 1.3×	147	10.9k
Francesco Paolo Schena	5.5k 1.2×	1.2k 0.7×	2.8k 1.8×	1.5k 1.0×	1.1k 0.7×	279	14.1k
Jicheng Lv	5.3k 1.2×	1.1k 0.6×	1.2k 0.8×	1.2k 0.8×	1.9k 1.3×	231	9.9k
Walter H. Hörl	4.2k 0.9×	2.5k 1.3×	2.2k 1.4×	1.5k 1.0×	927 0.7×	393	13.4k
Jack F.M. Wetzels	8.1k 1.8×	1.5k 0.8×	3.4k 2.2×	2.8k 1.9×	954 0.7×	394	14.3k
Richard J. Glassock	7.9k 1.7×	715 0.4×	2.0k 1.3×	2.5k 1.7×	1.2k 0.8×	261	12.8k
Kar Neng Lai	5.9k 1.3×	1.1k 0.6×	2.2k 1.5×	1.5k 1.0×	593 0.4×	354	12.9k
Shin‐Wook Kang	6.1k 1.3×	733 0.4×	2.2k 1.4×	1.7k 1.2×	1.4k 1.0×	530	12.4k
Kosaku Nitta	7.6k 1.6×	1.1k 0.6×	2.1k 1.4×	2.6k 1.8×	3.0k 2.1×	598	14.8k

Countries citing papers authored by Jérôme Rossert

Since Specialization

Citations

This map shows the geographic impact of Jérôme Rossert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Rossert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Rossert more than expected).

Fields of papers citing papers by Jérôme Rossert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Rossert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Rossert. The network helps show where Jérôme Rossert may publish in the future.

Co-authorship network of co-authors of Jérôme Rossert

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Rossert. A scholar is included among the top collaborators of Jérôme Rossert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Rossert. Jérôme Rossert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Little, Dustin J., Samvel B. Gasparyan, Patrick Schloemer, et al.. (2023). Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review. Journal of the American Society of Nephrology. 34(12). 1928–1935. 11 indexed citations

Heerspink, Hiddo J.L., Niels Jongs, Patrick Schloemer, et al.. (2023). Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression. Journal of the American Society of Nephrology. 34(12). 2025–2038. 15 indexed citations

Pollock, Carol A., Anna Żuk, Hans‐Joachim Anders, et al.. (2017). The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney International Supplements. 7(2). 130–137. 6 indexed citations

Himmelfarb, Jonathan, Glenn M. Chertow, Peter A. McCullough, et al.. (2017). Perioperative THR-184 and AKI after Cardiac Surgery. Journal of the American Society of Nephrology. 29(2). 670–679. 32 indexed citations

Skali, Hicham, Julie Lin, Marc A. Pfeffer, et al.. (2012). Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm. American Journal of Kidney Diseases. 61(2). 238–246. 12 indexed citations

Brideau, Gaëlle, Gerhard Wagner, Michael H. A. Roehrl, et al.. (2007). Scleraxis and NFATc Regulate the Expression of the Pro-α1(I) Collagen Gene in Tendon Fibroblasts. Journal of Biological Chemistry. 282(24). 17665–17675. 196 indexed citations

Rossert, Jérôme, Adeera Levin, Simon D. Roger, et al.. (2006). Effect of Early Correction of Anemia on the Progression of CKD. American Journal of Kidney Diseases. 47(5). 738–750. 103 indexed citations

Lefaucheur, Carmen, Bénédicte Stengel, Dominique Nochy, et al.. (2006). Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney International. 70(8). 1510–1517. 180 indexed citations

Levey, Andrew S., K-U Eckardt, Joseph Coresh, et al.. (2005). 慢性腎臓疾患の定義と分類:腎臓疾患からの位置記載:全体的な転帰(KDIGO)の改善. Kidney International. 67(6). 2089–2100. 6 indexed citations

10.

Rossert, Jérôme, Marc Froissart, & C. Jacquot. (2005). Anemia management and chronic renal failure progression. Kidney International. 68(99). S76–S81. 29 indexed citations

11.

Levey, Andrew S., Kai‐Uwe Eckardt, Yusuke Tsukamoto, et al.. (2005). Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International. 67(6). 2089–2100. 2833 indexed citations breakdown →

12.

Rossert, Jérôme, William M. McClellan, Simon D. Roger, Dierik Verbeelen, & Walter H. Hörl. (2002). Contribution of anaemia to progression of renal disease: a debate. Nephrology Dialysis Transplantation. 17(suppl_1). 60–66. 29 indexed citations

13.

Verrecchia, Franck, Alain Mauviel, & Jérôme Rossert. (2001). Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue Fibrosis. Journal of Investigative Dermatology. 116(5). 755–763. 104 indexed citations

14.

Tassart, M., et al.. (2001). Upper extremity digital subtraction venography with gadoterate meglumine before fistula creation for hemodialysis. Kidney International. 59(4). 1491–1497. 19 indexed citations

15.

Rossert, Jérôme. (2001). Drug-induced acute interstitial nephritis. Kidney International. 60(2). 804–817. 312 indexed citations

16.

Clemens, Thomas L., Sarah Cormier, Karlhans Endlich, et al.. (2001). Parathyroid hormone‐related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. British Journal of Pharmacology. 134(6). 1113–1136. 146 indexed citations

17.

Asherson, Ronald A., Ricard Cervera, Jean‐Charles Piette, et al.. (1998). Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients. Medicine. 77(3). 195–207. 369 indexed citations

18.

Alhenc‐Gelas, Martine, et al.. (1995). Pharmacokinetic Study of the Low-Molecular-Weight Heparin Fraxiparin in Patients with Nephrotic Syndrome. The Nephron journals/Nephron journals. 71(2). 149–152. 7 indexed citations

19.

Castedo, Maria, Lucette Pelletier, Jérôme Rossert, et al.. (1993). Mercury-induced autoreactive anti-class II T cell line protects from experimental autoimmune encephalomyelitis by the bias of CD8+ antiergotypic cells in Lewis rats.. The Journal of Experimental Medicine. 177(4). 881–889. 30 indexed citations

20.

Pelletier, Lucette, Renaud Du Pasquier, Jérôme Rossert, et al.. (1988). Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease.. The Journal of Immunology. 140(3). 750–754. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact